Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Comparative analysis of antifibrinolytic medications in pediatric heart surgery.

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

J Thorac Cardiovasc Surg. 2012 Mar;143(3):550-7. doi: 10.1016/j.jtcvs.2011.06.048. Epub 2012 Jan 20.

2.

Safety of aprotinin in congenital heart operations: results from a large multicenter database.

Pasquali SK, Hall M, Li JS, Peterson ED, Jaggers J, Lodge AJ, Jacobs JP, Jacobs ML, Shah SS.

Ann Thorac Surg. 2010 Jul;90(1):14-21. doi: 10.1016/j.athoracsur.2010.02.073.

3.

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.

Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C.

Crit Care. 2010;14(4):R148. doi: 10.1186/cc9216. Epub 2010 Aug 3.

4.

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

J Thorac Cardiovasc Surg. 2012 May;143(5):1069-76. doi: 10.1016/j.jtcvs.2011.08.051. Epub 2011 Nov 9.

5.

Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.

Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.

Eur J Cardiothorac Surg. 2009 Aug;36(2):322-9. doi: 10.1016/j.ejcts.2008.11.038. Epub 2009 Feb 27.

PMID:
19250838
6.

Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery.

Schindler E, Photiadis J, Sinzobahamvya N, Döres A, Asfour B, Hraska V.

Eur J Cardiothorac Surg. 2011 Apr;39(4):495-9. doi: 10.1016/j.ejcts.2010.07.026. Epub 2010 Sep 15.

PMID:
20832330
7.

The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.

Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P.

Eur J Cardiothorac Surg. 2009 Jan;35(1):167-71; author reply 171. doi: 10.1016/j.ejcts.2008.09.038. Epub 2008 Nov 21.

PMID:
19027313
8.

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.

Anesth Analg. 2010 Jan 1;110(1):21-9. doi: 10.1213/ANE.0b013e3181c0ea6d. Epub 2009 Nov 12.

PMID:
19910626
9.

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Eur J Cardiothorac Surg. 2011 Jun;39(6):892-7. doi: 10.1016/j.ejcts.2010.09.041. Epub 2010 Nov 5.

PMID:
21115357
10.

Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies.

Hutton B, Joseph L, Fergusson D, Mazer CD, Shapiro S, Tinmouth A.

BMJ. 2012 Sep 11;345:e5798. doi: 10.1136/bmj.e5798. Review.

11.

Antifibrinolytic drugs for acute traumatic injury.

Ker K, Roberts I, Shakur H, Coats TJ.

Cochrane Database Syst Rev. 2015 May 9;(5):CD004896. doi: 10.1002/14651858.CD004896.pub4. Review.

PMID:
25956410
12.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001886. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD001886.

PMID:
17943760
13.

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children.

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Ann Card Anaesth. 2015 Jan-Mar;18(1):23-6. doi: 10.4103/0971-9784.148316.

14.

The risk associated with aprotinin in cardiac surgery.

Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation.

N Engl J Med. 2006 Jan 26;354(4):353-65.

15.

Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.

Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J; Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation.

JAMA. 2007 Feb 7;297(5):471-9.

PMID:
17284697
16.

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators.

N Engl J Med. 2008 May 29;358(22):2319-31. doi: 10.1056/NEJMoa0802395. Epub 2008 May 14. Erratum in: N Engl J Med. 2010 Sep 23;363(13):1290.

17.

Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.

Martin K, Gertler R, Sterner A, MacGuill M, Schreiber C, Hörer J, Vogt M, Tassani P, Wiesner G.

Thorac Cardiovasc Surg. 2011 Aug;59(5):276-80. doi: 10.1055/s-0030-1250645. Epub 2011 Mar 21.

PMID:
21425054
18.

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):7978-87. eCollection 2015. Review.

19.

Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Büller HR.

Lancet. 1999 Dec 4;354(9194):1940-7.

PMID:
10622296
20.

Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery.

Falana O, Patel G.

Ann Pharmacother. 2014 Dec;48(12):1563-9. doi: 10.1177/1060028014549558. Epub 2014 Sep 11.

PMID:
25214649

Supplemental Content

Support Center